Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sotera Health (SHC) Shares Outstanding (Diluted Average) (2019 - 2025)

Sotera Health (SHC) has 6 years of Shares Outstanding (Diluted Average) data on record, last reported at $286.4 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 0.53% year-over-year to $286.4 million; the TTM value through Dec 2025 reached $286.4 million, up 0.53%, while the annual FY2025 figure was $286.4 million, 0.53% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $286.4 million in Q4 2025 per SHC's latest filing, roughly flat from $286.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $286.4 million in Q4 2025 and bottomed at $279.0 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $282.4 million, with a median of $283.0 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): rose 20.16% in 2021, then rose 0.16% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $279.4 million in 2021, then rose by 0.26% to $280.1 million in 2022, then grew by 1.12% to $283.2 million in 2023, then rose by 0.59% to $284.9 million in 2024, then grew by 0.53% to $286.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $286.4 million in Q4 2025, $286.0 million in Q3 2025, and $285.8 million in Q2 2025.